Skip to Content

GC1 (Mycophenolate mofetil 250 mg)

Pill imprint GC1 has been identified as Mycophenolate mofetil 250 mg.

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; dermatomyositis; autoimmune hepatitis; organ transplant, rejection prophylaxis; cogan's syndrome (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolate mofetil 250 mg GC1
Discount Card Promo
Mycophenolate mofetil
Imprint:
GC1
Strength:
250 mg
Color:
Blue / Peach
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Accord Healthcare Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide